Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 64,146 | 38,253 | 0 |
| Marketable Securities | N/A | 163,022 | 70,542 | 0 |
| TOTAL | $N/A | $245,306 | $114,602 | $0 |
| Non-Current Assets | ||||
| PPE Net | N/A | 859 | 1,207 | N/A |
| Investments And Advances | 0 | 0 | 11,380 | 0 |
| Other Non-Current Assets | 0 | 11,057 | 9,727 | 0 |
| TOTAL | $N/A | $11,916 | $22,314 | $N/A |
| Total Assets | $N/A | $257,222 | $136,916 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 2,446 | 1,912 | 0 |
| Accrued Expenses | N/A | 14,048 | 9,991 | 0 |
| TOTAL | $N/A | $18,562 | $15,920 | $0 |
| Non-Current Liabilities | ||||
| Deferred Revenues | N/A | 1,206 | 3,239 | N/A |
| Other Non-Current Liabilities | 0 | 5,144 | 5,801 | 0 |
| TOTAL | $N/A | $5,144 | $5,801 | $N/A |
| Total Liabilities | $N/A | $23,706 | $21,721 | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 42,436 | 45,373 | N/A | N/A |
| Retained earnings | N/A | -280,972 | -199,368 | 0 |
| Other shareholders' equity | 0 | 507,739 | 308,986 | 0 |
| TOTAL | $N/A | $233,516 | $115,195 | $0 |
| Total Liabilities And Equity | $0 | $257,222 | $136,916 | $0 |